Form CORRESP - Correspondence:
SEC Accession No. 0001193125-25-054054
Filing Date
2025-03-13
Accepted
2025-03-13 17:22:59
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 27471
2 GRAPHIC g937810g01g60.jpg GRAPHIC 2525
3 GRAPHIC g937810g16p59.jpg GRAPHIC 1278
4 GRAPHIC g937810g18w04.jpg GRAPHIC 1932
  Complete submission text file 0001193125-25-054054.txt   36825
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)